This site is intended for Healthcare Professionals only.

NPA commissions Professor David Taylor to evaluate impact of inflation on community pharmacies

Date:

Share post:

The National Pharmacy Association (NPA) has commissioned Professor David Taylor of University College London to investigate the implications of all-time high inflation rates on community pharmacies in the UK.

Professor Taylor’s will assess rates of inflation affecting community pharmacy across the UK, using public data sources whilst examining inflated costs in the context of the current five year contractual framework in England (2019-2024).

He would review the EY (Ernst & Young) report into pharmacy funding, to identify whether current inflationary pressures could change any of the findings and consider the policy implications and impacts of inflationary pressures, including pharmacy’s ability to prepare for a more clinically focused future and maintain current core services.

NPA chief executive Mark Lyonette said: “Inflationary pressures are eating into the limited funds provided by the NHS for pharmacy services. We believe the real level of inflation for pharmacy businesses could be higher than the CPI inflation rate, which itself is at a 40 year high. Staff and locum costs in the sector as well as medicines costs have risen dramatically.

“Everyone accepts there is a cost of living crisis; it’s time for government and NHS to acknowledge that our members are facing a ‘cost of doing business’ crisis. We believe that is standing in the way of service improvements and our ability to engage with a clinical future.

“By asking a distinguished academic to test our assumptions, we will have credible independent data to present to commissioners and pharmacy negotiators across the UK. Naturally we want this to lead to fair and realistic financial settlements for NPA members right across the UK.”

Professor Taylor said: “With GP practices under increasing pressure and their numbers falling, NHS community pharmacy could do more to enhance clinical outcomes in the English primary care system, as it is in other UK nations such as Scotland. I am committed to contrasting and analysing community pharmacy funding and developing policies as rigorously as possible from a public interest based standpoint.”

The report is due for publication this autumn.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

51% increase in pharmacy closure since last January-April: PM quizzed in the parliament

"There are over 10 and a half Community pharmacies across the country working incredibly hard to serve their...

BMI linked to work absenteeism, NHS expands obesity and type 2 diabetes programme

Wider rollout of NHS soup and shake diet to help 10,000+ with type 2 diabetes and obesity A recent...

GPhC appoints Louise Edwards as new Chief Strategy Officer

Louise will succeed Mark Voce who is taking early retirement from the GPhC’s position in July 2024 The General...

Community pharmacy patient safety group appoints new leadership

The new CPPSG's to bolster patient safety as community pharmacy expands services Jackie Giltrow and Jose Moss have been...